Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York.

Lux Health Tech Acquisition Corp.

Lux Capital is a venture capital firm that makes long-term bets on contrarians and outsiders. We believe the next generation of industrialist titans will be scientists, technologists and inventors who are doing more than challenging the status quo—they’re literally challenging the laws of physics. We have offices in New York City and Menlo Park.Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built an over $5 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.We invest in seed- and early-stage ventures across multiple sectors, including: 3D printing; machine learning; artificial intelligence; flying robots; surgical robots; synthetic biology; genomics; satellites; space; drones; computational imaging and recognition; new materials; holograms; “fixers” for the future; the internet of things; connected hardware; the smart home and virtual reality.

Zoox

Genocea Biosciences

Aeva

Aira

Auris Health

Tactic

Tempo Automation

Thrive Earlier Detection

Transphorm

CTRL-labs

Desktop Metal

Kala Pharmaceuticals

Latch

Matterport

Evolv Technology

Rigetti Computing

Science 37

Senti Biosciences

AirMap

Planet

Yonder

AltspaceVR

Shapeways

Recursion Pharmaceuticals

Resilience

Lux Capital

	Dec '20	Dec '21
net income	-244.72K -	27.10M 11,172.71%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital	911.92K -	478.02K 47.58%
accounts receivables
inventory
accounts payables	15.45K -	260.79 98.31%
other working capital	-15.45K -	477.76K 3,192.30%
other non cash items	-1.25M -	-27.58M 2,112.32%
net cash provided by operating activities	-579.29K -	-704.55 99.88%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites	-345M -
net cash used for investing activites	-345M -
debt repayment
common stock issued	25K -
common stock repurchased
dividends paid
other financing activites	346.19M -	484.55 100.00%
net cash used provided by financing activities	346.22M -	484.55 100.00%
effect of forex changes on cash
net change in cash	637.83K -	-637.41K 199.93%
cash at beginning of period		637.83K -
cash at end of period	637.83K -	417.82 99.93%
operating cash flow	-579.29K -	-704.55 99.88%
capital expenditure
free cash flow	-579.29K -	-704.55 99.88%

NASDAQ:LUXA

Lux Capital

Last Close

10.04

28/10 20:00

Volume Today

2.48M

Avg: 203.47K

PE Ratio

17.20

PFCF: -